Yang F , Xuan J , Chen J ,et al. HLA-B*59:01:a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese[J].Pharmacogenomics J, 2016,16(1):83-87. DOI:
10.1038/tpj.2015.25
.
Lerch M , Mainetti C , Terziroli Beretta-Piccoli B ,et al. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis[J].Clin Rev Allergy Immunol, 2018,54(1):147-176. DOI:
10.1007/s12016-017-8654-z
.
Mockenhaupt M , Viboud C , Dunant A ,et al. Stevens-Johnson syndrome and toxic epidermal necrolysis:assessment of medication risks with emphasis on recently marketed drugs.The EuroSCAR-study[J].J Invest Dermatol, 2008,128(1):35-44. DOI:
10.1038/sj.jid.5701033
.
Tangamornsuksan W , Lohitnavy M .Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis:a systematic review and meta-analysis[J].Pharmacogenomics J, 2019,19(3):286-294. DOI:
10.1038/s41397-018-0052-2
.
Xu HM , Cai HW , Li TY ,et al. Progress in sulfonamide hypersensitivity and cross-hypersensitivity[J].Chin J Pharmacol Toxicol, 2012,26(6):897-902. DOI:
10.3867/j.issn.1000-3002.2012.06.021
.
Goto CitationGoogle ScholarBaidu ScholarWanfang Data
Li J , Xing Q , Lu J ,et al. Analysis ofStevens-Johnson syndrome and toxic epidermal necrolysis induced by methazolamide[J].Chin J Ocul Traum Occupat Eye Dis, 2018,40(9):708-711. DOI:
10.3760/cma.j.issn.2095-1477.2018.09.021
.
Goto CitationGoogle ScholarBaidu ScholarWanfang Data
[10]
Kim SH , Kim M , Lee KW ,et al. HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis[J].Pharmacogenomics, 2010,11(6):879-884. DOI:
10.2217/pgs.10.54
.
She QY , Dong YY , Deng YH . 《UK Guidelines for the Management of StevenseJohnson Syndrome/Toxic Epidermal Necrolysis in Adults 2016》 unscramble[J].China Med Abstracts Dermatol, 2017,34(3):273-278.
Goto CitationGoogle ScholarBaidu ScholarWanfang Data